A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 24
[Display Entries]
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : dPT
Long Form : dilute prothrombin time
No. Year Title Co-occurring Abbreviation
2020 Novel assay based on diluted prothrombin time reflects anticoagulant effects of direct oral factor Xa inhibitors: Results of multicenter study in Japan. APTT, DXaIs, PT, RITG
2019 Marstacimab, a tissue factor pathway inhibitor neutralizing antibody, improves coagulation parameters of ex vivo dosed haemophilic blood and plasmas. rFIX, rFVIII, ROTEM, TFPI, TGA
2018 Pharmacokinetics and Pharmacodynamics of an Oral Formulation of Apixaban in Horses After Oral and Intravenous Administration. DOAC, EHV-1, PO, UPLC-MS
2017 Mechanistic Modeling of the Pharmacodynamic and Pharmacokinetic Relationship of Tissue Factor Pathway Inhibitor-Neutralizing Antibody (BAY 1093884) in Cynomolgus Monkeys. PD, PK, TFPI
2016 A single test to assay warfarin, dabigatran, rivaroxaban, apixaban, unfractionated heparin, and enoxaparin in plasma. ACs, dFiix-PT, DOACs, TP, UFH
2015 Interactions between rivaroxaban and antiphospholipid antibodies in thrombotic antiphospholipid syndrome. aPL, APS, dRVVT, LA, NC, PNP, TVT/ECT
2014 Inhibitory effects of LDL-associated tissue factor pathway inhibitor. FXa, TFPI, TFPI
2013 Direct thrombin inhibitors and factor xa inhibitors can influence the diluted prothrombin time used as the initial screen for lupus anticoagulant. LA
2012 Drug-induced lupus anticoagulants and antiphospholipid antibodies. APS, APTT, dRVVT, KCT, LA, SLE
10  2012 New guidelines for lupus anticoagulant: sensitivity and specificity of cut-off values calculated with plasmas from healthy controls in mixing and confirmatory tests. APTT, dRVVT, ICA, LA, OA, SEN, SPC
11  2012 TFPI resistance related to inherited or acquired protein S deficiency. PS, TFPI, TFPI NR
12  2011 Antiplatelet, anticoagulant, and fibrinolytic activity in vitro of extracts from selected fruits and vegetables. APTT, KCT, PT
13  2011 Lupus anticoagulant: performance of the tests as recommended by the latest ISTH guidelines. APTT, dRVVT, LA, OR
14  2010 Amphipathic peptides can act as an anticoagulant by competing with phospholipid membranes for blood coagulation factors. APTT, dRVVT, IAP
15  2009 Diluted Russell viper-venom time improves identification of antiphospholipid syndrome in a lupus anticoagulant-positive patient population. aCL, APS, CI, dRVVT, LA, OR, ROC
16  2006 Improved coagulation in bleeding disorders by Non-Anticoagulant Sulfated Polysaccharides (NASP). NASP, NASPs, PPS, TFPI
17  2006 Tissue factor pathway inhibitor anticoagulant activity: risk for venous thrombosis and effect of hormonal state. DVT, OR, TFPI
18  2004 A two-step coagulation test to identify antibeta-glycoprotein I lupus anticoagulants. dRVVT, LA, PL
19  2002 Dilute prothrombin time-based lupus ratio test. Integrated LA testing with recombinant tissue thromboplastin. CV, dAPTT, dRVVT, LA, LR, NP, PL
20  1999 Do antiphospholipid antibodies interfere with tissue factor pathway inhibitor? APA, LAs, TFPI
21  1999 Lupus anticoagulant testing in Europe: an analysis of results from the first European Concerted Action on Thrombophilia (ECAT) survey using plasmas spiked with monoclonal antibodies against human beta2-glycoprotein I. aCL, beta1GPI, beta2GPI, dRVVT, ECAT, LA
22  1997 Tissue factor pathway inhibitor in complex with low density lipoprotein isolated from human plasma does not possess anticoagulant function in tissue factor-induced coagulation in vitro. LDL, TF, TFPI
23  1996 Depletion of intravascular pools of tissue factor pathway inhibitor (TFPI) during repeated or continuous intravenous infusion of heparin in man. TF, TFPI, TFPI Ag
24  1994 Optimization of the dilute prothrombin time for the detection of the lupus anticoagulant by use of a recombinant tissue thromboplastin. CVs, LA